Showing 15,121 - 15,140 results of 47,188 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 1.26s Refine Results
  1. 15121

    <b>LINEAR PROGRAMMED DIETARY PLAN DATASET </b><b>ON IMPROVING ENERGY INTAKE AMONG CHILDREN LIVING WITH HIV AGED 2-5 YEARS</b>a by Harriet Carin (17951636)

    Published 2024
    “…</p><p dir="ltr">There was a significant increase in mean knowledge change (mean change) =2.48(95%CI=1.5-3.3), P=<0.01) as a result of an intervention (F=5.1; P=0.025) with an effect size of (Cohen’s d=0.5{95%CI=0.21-0.78}.The mean change for attitude was 8.49{95%CI=7.02-9.96}, P=<0.001 with significant strength of the intervention F=48.9; P=0.001) with effect size (Cohen’s d =1.2{95%CI=0.87-1.48}.The mean change for energy intake was 351.82(95%CI =303.20-400.44}, P=<0.001) with significant strength of the intervention F=57.95; P=0.001) and effect size (Cohen’s d=1.5(1.29-1.73)</p><p dir="ltr">The intervention effectively increased knowledge and changed attitudes, increasing energy intake among this population.…”
  2. 15122

    Data_Sheet_1_Forced changes in El Niño–Southern Oscillation due to global warming and the associated uncertainties in ACCESS-ESM1.5 large ensembles.docx by Harun A. Rashid (13258725)

    Published 2022
    “…There is a modest but statistically significant GW-induced increase in the ensemble-mean ENSO amplitude and a sizable ensemble variation (due to internal variability) with both increases (in 80% of the members) and decreases. …”
  3. 15123
  4. 15124
  5. 15125

    Table_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.DOCX... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  6. 15126

    Image_3_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  7. 15127

    Image_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  8. 15128

    Image_2_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  9. 15129
  10. 15130
  11. 15131

    <b>L-Tryptophan as a Frontier in Diabetes Management: A Pilot Study</b> by dr.gayathri M rao (22045067)

    Published 2025
    “…On 11th day after sacrifice, Intestinal absorption of glucose, Pancreatic and intestinal Na+-K+ ATPase (NKA) activity, intestinal Nitric Oxide (NO), Blood & pancreatic Glucagon like peptide-1(GLP-1), serum total protein, urea and cholesterol, liver and pancreatic histology were studied.</p><p dir="ltr">A significant decrease in the glucose absorption and blood glucose level in the tryptophan treated diabetic group in comparison with diabetic controls. …”
  12. 15132
  13. 15133
  14. 15134
  15. 15135
  16. 15136
  17. 15137
  18. 15138
  19. 15139
  20. 15140